Patents by Inventor Inge E.A. Flesch

Inge E.A. Flesch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Chaperonin 10-induced immunomodulation
    Patent number: 9457062
    Abstract: The present invention relates to methods for modulating Toll-like receptor signalling in a subject, or in at least one cell, tissue or organ thereof, methods for treating or preventing a disease or condition in a subject, methods for modulating the production and/or secretion of one or more immunomodulators in a subject, or at least one cell, tissue or organ thereof, wherein said methods involve the administration of chaperonin 10, and wherein the chaperonin 10 associates with a Toll-like receptor in an activation cluster. Also contemplated are associated compositions and uses thereof.
    Type: Grant
    Filed: July 11, 2006
    Date of Patent: October 4, 2016
    Assignee: CBIO LIMITED
    Inventors: Barbara J. Johnson, Caroline A. Dobbin, Dean J. Naylor, Linda A. Ward, Inge E. A. Flesch, Christopher B. Howard
  • Regulation of immune responses by modulation of the function of antigen presenting cells
    Patent number: 8796225
    Abstract: The present invention relates to the use of chaperonin 10 to modulate the function of antigen presenting cells. More particularly the invention resides in the modulation of cell surface expression of MHC molecules such as HLA.
    Type: Grant
    Filed: March 1, 2007
    Date of Patent: August 5, 2014
    Assignee: CBIO Limited
    Inventors: Barbara Jane Johnson, Caroline Amanda Dobbin, Inge E A Flesch
  • REGULATION OF IMMUNE RESPONSES BY MODULATION OF THE FUNCTION OF ANTIGEN PRESENTING CELLS
    Publication number: 20100256059
    Abstract: The present invention relates to the use of chaperonin 10 to modulate the function of antigen presenting cells. More particularly the invention resides in the modulation of cell surface expression of MHC molecules such as HLA.
    Type: Application
    Filed: March 1, 2007
    Publication date: October 7, 2010
    Applicant: CBIO LIMITED
    Inventors: Barbara Jane Johnson, Caroline Amanda Dobbin, Inge E A Flesch
  • CHAPERONIN 10-INDUCED IMMUNOMODULATION
    Publication number: 20090047240
    Abstract: The present invention relates to methods for modulating Toll-like receptor signalling in a subject, or in at least one cell, tissue or organ thereof, methods for treating or preventing a disease or condition in a subject, methods for modulating the production and/or secretion of one or more immunomodulators in a subject, or at least one cell, tissue or organ thereof, wherein said methods involve the administration of chaperonin 10, and wherein the chaperonin 10 associates with a Toll-like receptor in an activation cluster. Also contemplated are associated compositions and uses thereof.
    Type: Application
    Filed: July 11, 2006
    Publication date: February 19, 2009
    Applicant: CBio LIMITED
    Inventors: Barbara J. Johnson, Caroline A. Dobbin, Dean J. Naylor, Linda A. Ward, Inge E.A. Flesch, Christopher B. Howard